Point72 Asset Management’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-760,870
| Closed | -$3.81M | – | 1390 |
|
|
2023
Q4 | $3.81M | Sell |
760,870
-420,200
| -36% | -$2.11M | 0.01% | 774 |
|
|
2023
Q3 | $4.97M | Buy |
1,181,070
+49,647
| +4% | +$209K | 0.01% | 707 |
|
|
2023
Q2 | $4.56M | Sell |
1,131,423
-19,225
| -2% | -$77.5K | 0.01% | 689 |
|
|
2023
Q1 | $3.24M | Hold |
1,150,648
| – | – | 0.01% | 747 |
|
|
2022
Q4 | $3.54M | Buy |
+1,150,648
| New | +$3.54M | 0.01% | 691 |
|
|
2022
Q2 | – | Sell |
-128,000
| Closed | -$1.01M | – | 1023 |
|
|
2022
Q1 | $1.01M | Hold |
128,000
| – | – | ﹤0.01% | 868 |
|
|
2021
Q4 | $1.08M | Buy |
+128,000
| New | +$1.08M | ﹤0.01% | 840 |
|
|
2020
Q3 | – | Sell |
-44,000
| Closed | -$3.21M | – | 838 |
|
|
2020
Q2 | $3.21M | Sell |
44,000
-23,000
| -34% | -$1.68M | 0.02% | 513 |
|
|
2020
Q1 | $3.52M | Sell |
67,000
-1,000
| -1% | -$52.5K | 0.03% | 408 |
|
|
2019
Q4 | $5.56M | Buy |
+68,000
| New | +$5.56M | 0.03% | 453 |
|
|
2018
Q1 | – | Sell |
-6,312
| Closed | -$2.5M | – | 761 |
|
|
2017
Q4 | $2.5M | Sell |
6,312
-1,962
| -24% | -$777K | 0.01% | 577 |
|
|
2017
Q3 | $3.53M | Buy |
+8,274
| New | +$3.53M | 0.02% | 493 |
|